Daily Management Review

Pfizer Lowers Its Top Profit Margin Following The Third Quarter’s Earnings


11/04/2016


The “average analyst” forecast of Pfizer’s earnings were missed by one percent per share.



The largest manufacturer of drugs in the U.S., Pfizer Inc., issued its “quarterly adjusted profit” which just fell a little short on standing up to the estimates of the analysts, while four cents were shaved off by the company from its “2016 earnings forecast” following the decision of putting an end to the plans of developing “cholesterol-lowering treatment”.
 
Putting aside the “special items”, Pfizer’s third quarter’s earning equals to sixty one percent per share, whereby the estimates made by the “average analyst” was missed by one percent, reports “Thomson Reuters I/B/E/S”. Ibrance is a treatment for breast cancer developed by Pfizer which brought in sale’s revenue of “$550 million”. However, it missed the “$576 million” forecast of consensus which was compiled by “Evercore ISI”.
 
On the other hand, the pain drug, Lyrica, generated sales amount of “$1.05 billion”, which too failed to meet the expectation of “$1.28 billion”, whereas the sale of “Prevnar vaccine” over shot the forecast of “$1.48 billion” and brought in “$1.54 billion”. Furthermore, Pfizer reported that it will abandon the development of “bococizumab”, a drug for lowering cholesterol, reason being cited as an “evolving treatment landscape”.
 
As a result, Pfizer brought down the top earning forecast margin of 2016 to “$2.43”, while it maintained the “lower end at $2.38”. Moreover, the company increased its “revenue forecast” from “$51 billion” to “$52 billion”, yet retained the upper limit at “$53 billion”. According to Reuters:
“Bococizumab, which belongs to a pricey new class of medicines called PCSK9 inhibitors, was always going to be late to the party, since two rival drugs hit the market last summer - Praluent, co-developed by Regeneron (REGN.O) and Sanofi SA (SASY.PA) and Repatha from Amgen Inc (AMGN.O)”.
 
 
 
 
References:
http://www.reuters.com/







Science & Technology

Wreck Of Russian Ship Rumoured To Have 5,500 Boxes Of Gold Found Near South Korean Island

Gene Editing of Human Embryo Could Find ‘Moral’ Grounds: UK’s Ethics Council

Baidu comes up with a self-driving bus

Developing countries are stepping up their own space programs

McAfee: Number of cybercrime attacks skyrocketed

RemoveDebris Mission To Clear Debris Of In Orbit Over Earth

British experts: Online gambling is dangerous

Vodafone Chooses ‘Highly Trafficked Urban’ Space As Its 5G Testing Grounds

Space To Become A Travel Destination By 2022

Dream Of Immortality Can Be Realised By 2045

World Politics

World & Politics

Germany asks to return € 4 thousand subsidies for the purchase of Tesla

Was Trump's visit to the UK the last straw?

Prime Minister May Could Alter Brexit Strategies, Said Ress-Mogg

Le Maire: The US refused to release France from anti-Iran sanctions

One Belt, One Road is facing difficulties around the world

Qatar to raise $ 4 billion to buy Eurofighter Typhoon jets

The UK sets to turn all cars zero-emission by 2030

Brexit Minister’s Resignation States May’s Brexit Policies Weakening The Country’s Stance